Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report

Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Mayur D., Ravindranathan, Deepak, Gill, Harpaul S., Kota, Vamsi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298514/
https://www.ncbi.nlm.nih.gov/pubmed/28203579
http://dx.doi.org/10.1177/2324709617690747
_version_ 1782505877242118144
author Mody, Mayur D.
Ravindranathan, Deepak
Gill, Harpaul S.
Kota, Vamsi K.
author_facet Mody, Mayur D.
Ravindranathan, Deepak
Gill, Harpaul S.
Kota, Vamsi K.
author_sort Mody, Mayur D.
collection PubMed
description Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.
format Online
Article
Text
id pubmed-5298514
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-52985142017-02-15 Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report Mody, Mayur D. Ravindranathan, Deepak Gill, Harpaul S. Kota, Vamsi K. J Investig Med High Impact Case Rep Case Report Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia. SAGE Publications 2017-02-01 /pmc/articles/PMC5298514/ /pubmed/28203579 http://dx.doi.org/10.1177/2324709617690747 Text en © 2017 American Federation for Medical Research http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Mody, Mayur D.
Ravindranathan, Deepak
Gill, Harpaul S.
Kota, Vamsi K.
Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title_full Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title_fullStr Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title_full_unstemmed Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title_short Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report
title_sort rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298514/
https://www.ncbi.nlm.nih.gov/pubmed/28203579
http://dx.doi.org/10.1177/2324709617690747
work_keys_str_mv AT modymayurd rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemiaacasereport
AT ravindranathandeepak rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemiaacasereport
AT gillharpauls rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemiaacasereport
AT kotavamsik rhabdomyolysisfollowinginitiationofposaconazoleuseforantifungalprophylaxisinapatientwithrelapsedacutemyeloidleukemiaacasereport

Ejemplares similares